Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer.
暂无分享,去创建一个
[1] A. R. Kendall,et al. Immunoperoxidase localization of prostate‐specific antigen , 1982, The American journal of surgical pathology.
[2] T. Stamey,et al. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate , 1990, Cancer.
[3] G. Murphy,et al. Histologic grading of primary prostatic cancer: a new approach to an old problem. , 1980, The Journal of urology.
[4] T. Wheeler. Anatomic considerations in carcinoma of the prostate. , 1989, The Urologic clinics of North America.
[5] R. Babaian,et al. Prostate‐Specific Antigen and External Beam Radiation Therapy in Prostate Cancer , 1991, Cancer.
[6] T. Stamey,et al. Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.
[7] M. Resnick,et al. Tissue concentrations of prostate‐specific antigen in prostatic carcinoma and benign prostatic hyperplasia , 1991, International journal of cancer.
[8] D. Tindall,et al. In situ hybridization of prostate-specific antigen mRNA in human prostate. , 1990, The Journal of urology.
[9] T. Stamey,et al. Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .
[10] T. Stamey,et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. , 1989, The Journal of urology.
[11] J. Epstein,et al. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications. , 1984, Human pathology.
[12] S. Kagawa,et al. Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen. , 1984, Urologia internationalis.
[13] J. Trachtenberg,et al. Adenocarcinoma of the Prostate , 1988 .
[14] R. Stephenson,et al. Prostate specific antigen in patients with clinical stage C prostate cancer: relation to lymph node status and grade. , 1991, The Journal of urology.
[15] F. Mostofi,et al. Grading of prostatic carcinoma. , 1975, Cancer chemotherapy reports.
[16] H. Fritsche,et al. Monoclonal prostate‐specific antigen in untreated prostate cancer. Relationship to clinical stage and grade , 1991, Cancer.
[17] D E Johnson,et al. Histologic grading study of prostate adenocarcinoma: The development of a new system and comparison with other methods—A preliminary study , 1982, Cancer.
[18] P. Scardino,et al. Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis. , 1991, British journal of urology.
[19] J. Masters,et al. Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice. , 1985, British journal of urology.
[20] J. Oesterling,et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. , 1990, The Journal of urology.
[21] J. Oesterling,et al. Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade. , 1993, Urology.